Product Information
VILAZODONE HCL 40 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.8400 per EA under NDC 69097098202. Its NADAC has been published 157 times since Oct 4, 2023.
FDA first approved this application on Apr 7, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/1
Manufacturer
Cipla USA Inc.NDC
69097098202
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VILAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208200FDA Approved
4/7/2021
TE Code
AB
On Market Since
1/23/2023
Price Statistics
The NADAC for VILAZODONE HCL 40 MG TABLET has been published 157 times since Oct 4, 2023, and over the history we have for it it has declined 43.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8400 per EA |
|---|---|
| All-time high | $1.6346 (Dec 13, 2023) |
| All-time low | $0.8400 (Sep 23, 2026) |
| 52-week high | $1.2319 |
| 52-week low | $0.8400 |
| Median price | $1.0912 |
| Average price | $1.1428 |
| Largest weekly change | -29.2% (Jul 17, 2024) |
| Weeks tracked | 157 |
| Tracking since | Oct 4, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vilazodone hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VILAZODONE HCL 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VILAZODONE HCL 40 MG TABLET, manufactured by Cipla USA Inc., is $0.8400 per EA (NDC 69097098202), effective Sep 30, 2026.
How has the price of VILAZODONE HCL 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for VILAZODONE HCL 40 MG TABLET has declined 43.9%. It has been tracked across 157 weekly CMS publications since Oct 4, 2023.
What are the highest and lowest recorded NADAC prices for VILAZODONE HCL 40 MG TABLET?
Since Oct 4, 2023, the NADAC for VILAZODONE HCL 40 MG TABLET has ranged from a low of $0.8400 (Sep 23, 2026) to a high of $1.6346 (Dec 13, 2023), with a median of $1.0912 per EA.
Are there cheaper alternatives to VILAZODONE HCL 40 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VILAZODONE HCL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VILAZODONE HCL 40 MG TABLET?
VILAZODONE HCL 40 MG TABLET (NDC 69097098202) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.